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Risk factors of Gestational Diabetes Mellitus Among  
Saudi Women 
 




Objective: The aim of this study was to identify the main risk factors of Gestational Diabetes Mellitus 
among Saudi women. 
Methodology: This is a case control laboratory-based study conducted in Wadi Al Dawasir City in Saudi 
Arabia.600 pregnant women as follows; 300 screened pregnant women as the study group and 300 non 
screened pregnant women as the control group.Selection Criteria for the screened group: Should be booked 
at 28 weeks or before that, not known to be diabetic before pregnancy or diagnosed as cases of GDM before 
24 weeks. Selection Criteria for the non-screened group: They were not diagnosed before pregnancy as 
cases of DM or diagnosed during pregnancy as cases of GDM.Screening for GDM: Screening for GDM 
was a routine using loading dose glucose (LDG) or glucose challenge test (GCT) between 24-28 weeks 
gestation according to the hospitals protocol. The pregnant women were classified into high risk or low risk 
according to the following characteristics 
 Results: Risk factors in the screened mothers with positive LDG result was: family history was identified 
in 56.1% (23/41) of mothers and it was absent in 43.8% (18/41). The next main risk factor among the 
mothers with positive LDG results was a history of baby weight 4 kg or more and was found in 9.76% 
(4/41) followed by history of intrauterine fetal death that was detected in 7.32% (3/41). Only one mother 
2.44% (1/41) had past history of gestational diabetes mellitus similar to mothers with history of babies with 
congenital malformation that was detected in 2.44% (1/41) also. Family history was the main risk factor 
among mothers with positive LDG results as it was found in 56.1%. Within the 20 mothers with significant 
oral glucose tolerance test (OGTT) results, 80% (16/20) had risk factors and 20% (4/20) had no risk factors. 
Conclusion: Identifying of risk factors is important for screening for GDM but even women with low risk 
and no risk factors should be screened for GDM. 
 
Introduction: 
Pregnancies complicated with GDM present a public health problem of a major proportion. They 
are generally classified as high risk and require more intensive obstetrical supervision. It is 
associated with increase in both diabetes and pregnancy related complications(1). It has been 
reported that 50% of these patients with GDM will become diabetic in 15 years following 
pregnancy (2) especially for those over weight (46.7%) (3). Intrauterine exposure to diabetes 
conveys a high risk for the development of diabetes and obesity in offspring in excess of risk 
attributable to genetic factors alone (4). Also they are more liable to develop slowly progressive 
form of abnormal glucose tolerance in addition to overt diabetes(5). Early clinical recognition of 
GDM is important because therapy, including medical nutrition therapy (MNT), insulin when 
necessary, and antepartum fetal surveillance, can reduce the well described GDM-associated 
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neonate weighing more than 4 kg or a prior neonatal death, congenital anomaly or family history 
of overt diabetes, clinical finding during pregnancy that include obesity, excessive weight gain, 
glycosuria, proteinuria and hypertension(6). Several investigators have examined the efficiency of 
these risk factors and narrowing the groups to be screened very consistently. These investigators 
have found these risk factors only in roughly half of the women known to have GDM. That means 
if risk factors alone determined who was to be screened, half of all cases of GDM would not be 
detected (6). Many investigators found that minor abnormalities of glucose metabolism without 
GDM are significant risk factors for fetal over growth (7).  
Although there is less risk of gestational diabetes in low risk women, the prevalence is still high 
enough to make testing for gestational diabetes worthwhile. Furthermore low risk women with 
GDM are at equal risk for complications (8). It was found that over half of all patients who exhibit 
an abnormal GTT lack the risk factors mentioned above and 35% of all cases of GDM will be miss 
diagnosed if an arbitrary age cut-off of 30 years used for screening (6). It is therefore recommended 
that all pregnant women should be screened for gestational diabetes. 
In Saudi Arabia the available data suggests that the incidence of hyperglycemia is high (9,10,11,12). 
The high incidence may in turn influence the incidence of gestational diabetes in the population 
(12). Also the changing socioeconomic status of Saudi is culminating in the affluence enjoyed by 
the population could be a factor (9,10). Also the climatic condition and the general life pattern that 
favours sedentary lifestyle prevents them exercising. The dietary habits, rich food in carbohydrates 
and high consumption of dates, the increase prevalence of obesity in addition to genetic factors 
(10). All these factors predispose gravid Saudi women to develop diabetes mellitus. 




Study area: The research was conducted in Wadi Al Dawasir City in Saudi Arabia. 
Study population: The population number in Wad Al Dawasir is about 80.000 – 120.000. The 
main health problem in this area is Diabetes Mellitus. Women are rarely allowed for outdoor walk 
with limited activities.  
Sample Size and design: 600 pregnant women as follows of them 300 screened pregnant women 
as study group and 300 non screened pregnant women as control group. 
A sample size was estimated using a sample size derivation. Since the prevalence is 30% thus p is 
0.3 and q is 0.7. 
The sample size (n) is determined by using the following formula 
   n = z2pq  where d is 0.05, z is 2. 
      d2 
n = (2)2(30) (70)/25= 336 (This is the minimum sample size) 
Selection Criteria for the screened group: Should be booked at 28 weeks or before that, not 
known to be diabetic before pregnancy or diagnosed as cases of GDM before 24 weeks.  
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cases of DM or diagnosed during pregnancy as cases of GDM. 
Site of Data Collection: Relevant data was collected from all women by the author himself. For 
the screened group the information was collected in the Antenatal Clinic of Armed Forces Hospital 
and Sulayyil Military Clinic .For the non-screened group the information was obtained from the 
mothers in the Ministery of Health (MOH) hospital. 
Screening for GDM: Screening for GDM was a routine using loading dose glucose (LDG) or 
glucose challenge test (GCT) between 24-28 weeks gestation according to the hospitals protocol. 
Random Blood Glucose was done in the first visit for all pregnant women booked before 24 weeks 
(antenatal screening). 100 gm OGTT was done for all cases with blood glucose more than 10 
mmol/L. 
The pregnant women were classified into high risk or low risk according to the following methods: 
OGTT It was the main test performed during pregnancy to diagnose gestational diabetes mellitus 
(GDM), it was 3 hours test using 100 g glucose (4) according to the hospital protocol.    
Data Analysis: All collected data were analysis by the SPSS. Probability/t-test was used to assess 
the significance of the results. 
Consent: Consent was obtained from all participants.  
 
Results: 
In this descriptive interventional study we screened 300 pregnant women in order to detect the 
possible risk factors among them.Of the 300 screened pregnant women 22 were less than 20 years 
old distributed as follows: 95.5% (21/22) were normal and 4.5% (1/22) had GDM. Mothers at the 
age (20 – 29 years) were 199, 95.5% (190/199) were normal and 4.5% (9/199) proved to have 
GDM.Among the pregnant screened women in the age group 30 – 39 years 8.6% (6/70) had GDM 
and 91.4% (64/70) were normal. Of the 9 mothers at 40 years old and above, cases with GDM 
represent 44.4% (4/9) and 45.6% (5/9) were normal.The number of mothers with GDM increases 
with the increase of age compared to the normal and the difference between the two groups was 
statistically significant as Chi square test value = 22.680, df = 3, P. value = .000 which was highly 
significant. (More details in table 1). 
When all cases of GDM (intolerance + GDM) were compared with normal mothers, the mean body 
mass index of the diabetic group was 29.5122 slightly higher than the mean body mass index of 
the normal mothers (27.6388). The difference between them is not significant. As T test = 1.491, 
df = 3 significance = 0.298. (Table 2) 
It was found that 9.9% (7/71) primgravidae had LDG result > 7.8 mmol/L compared to 90.1% 
(64/71) primgravidae with LDG results less than or equal to 7.8 mmol/L. The percentage slightly 
increased in multiparous (up to 5 children) where 11.4% (21/185) mothers had positive LDG result 
compared to 88.6% (164/185) multiparous with negative LDG result. 30 (13/44) mothers who had 
more than 5 children had LDG result more than 7.8 mmol/L compared to 31 (31/44) 70.5% 
obtained LDG result less than 7.8 mmol/L 
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primgravidae and multiparous mothers. The difference between the two groups was statistically 
highly significant as X2 test value = 11.115, df = 2 and P. value = 0.00030. (Table 3) 
Gestational diabetes mellitus was diagnosed in 36.6% (15/41) mothers with positive LDG test. 
12.2% (5/41) mothers were found to have an impaired glucose tolerance test. The remaining 51.2% 
(21/41) mothers had normal OGTT test. Nearly half of the mothers with positive LDG results were 
found to have abnormal OGTT (GDM + IOGTT).  Mothers with IOGTT were managed as cases 
of GDM though screening test identified nearly half of mothers with GDM. (Table 4) 
About 22% (9/41) women had no risk factors and more than two thirds 78% (37/41) of the mothers 
with positive LDG result had risk factors. As more than 2/3 of mothers with positive LDG results 
had risk factors, so risk factors are predictive for diagnosis of GDM. 22% of mothers with positive 
LDG results would have been missed if screening for GDM was performed for mothers with 









Table 1: Distribution of mothers with GDM according to their age   compared to the normal 
mothers (N=300) 
 
Age groups GDM Normal Total 
Less than 20 years 1 (4.5%) 21 (95.5%) 22 (100%) 
20 – 29 years 9 (4.5%) 190 (95.5%) 199 (100%) 
30 – 39 years 6 (8.6%) 64 (91.4%) 70 (100%) 
40 years & above 4 (44.4%) 5 (45.6%) 9 (100%) 
Total 20 (6.7%) 280 (93.3%) 300 (100%) 
 
X2 = 22.680,    df = 3   P. value = .000 
 
Table 2: Shows the comparison between the mean of the body mass index (BMI) of cases 
with GDM and normal mothers (N = 300) 
 
Final diagnosis N Mean of MBI Std deviation Std error of mean 
GDM 20 29.5122 5.4353 1.2154 
Normal 280 27.6388 5.4262 3243 
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Table 3: Shows the results of LDG test in relation to parity (number of children has been 
delivered by the patient (N = 300) 
 
Number of children  Result of LDG test Total 
7.8 mmol/L  or 
less 
More than 7.8 
mmol/L 
PG 64 (90.1%) 7 (9.9%) 71 (23.7%) 
1 – 5 multiparous 164 (88.6%) 21 (11.4%) 185 (61.7) 
<5 )GM) 31 (70.5%) 13 (29.5%) 44 (14.7%) 
Total 259 (86.3%) 41 (13.7%) 300 (100%) 
 
X = 11.115               df = 2             P value = 0.00030 
 
Risk factors in the screened mothers with positive LDG result. Family history was identified in 
56.1% (23/41) of mothers and it was absent in 43.8% (18/41). 
The next main risk factor among the mothers with positive LDG results was a history of baby 
weight 4 kg or more and was found in 9.76% (4/41) followed by a history of intrauterine fetal 
death that was detected in 7.32% (3/41). Only one mother 2.44% (1/41) had past history of 
gestational diabetes mellitus similar to mothers with history of babies with congenital 
malformation that was detected in 2.44% (1/41) also. Family history was the main risk factor 
among mothers with positive LDG results as it was found in 56.1%. (Table 6) 
Within the 20 mothers with significant OGTT results, 80% (16/20) had risk factors and 20% (4/20) 
had no risk factors. 
In mothers with positive LDG results and negative OGTT, 23.8% (5/21) had no risk factors while 
76.2% (16/21) had risk factors. In 41 mothers with positive LDG results 78.0% (32/41) had risk 
factors.Risk factors used in this study predicted 80% of cases of GDM and 76.2% of those with 
positive LDG results and normal OGTT. The difference between the two groups was statistically 
not significant as X2 test value = 0.007, df =  1 P value = 0.9340.  As there was no difference 
between mothers with GDM and those with positive LDG results and normal OGTT, new cases 
of GDM were expected to be diagnosed among mothers with positive LDG results and normal 
OGTT, if OGTT was repeated at different gestational age (between 24 to 36 weeks). (Table 7) 
There were 20.0% (4/20) mothers with GDM who had no risk factors compared to 23.0% (5/21) 
mothers with positive LDG results and normal OGTT. About 50.0% (10/20) of cases with GDM 
had one risk factor compared to 42.9% (9/21) mothers with positive LDG results and normal 
OGTT. 20.0% (4/20) diabetic mothers had 2 risk factors compared to 33.3% (7/21) mothers with 
positive LDG results and normal OGTT. 
None of the pregnant women with positive LDG results and normal OGTT had 3 or 4 risk factors 
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The number of risk factors was more among mothers with GDM compared to mothers with 
positive LDG results and normal OGTT. The difference between the two groups was not 
significant as X2 test value = 2.959, df = 9, P value = 0.5647. (Table 8) 
 
 
Table 4: The final result of oral glucose tolerance test OGTT for all mothers with LDG test 
more than 7.8 mmol/L (N = 41) 
 
Final diagnose Frequency Percent 
Gestational Diabetes Mellitus (GDM 15 36.6% 
Impaired Oral Glucose Tolerance Test  5 12.2% 
Normal OGTT 21 51.2% 
Total 41 100% 
 
 
Table 5: Number of cases with risk factors and those without risk factors among mothers 
with LDG result more than 7.8 mmol/L (N  =  41) 
 
Cases with LDG result >7.8 mmol/L No. of cases 
Mothers with no risk factors 9 (22%) 
Cases with risk factors 32 (78%) 
Total 41 (100%) 
 
 
Table 6: Distributions and types of risk factors among mothers with positive LDG results (N 
= 41) 
 





Past history of GDM 1 (2.44%) 40 (97.56%)  
 
41 (100 %) 
Family history of DM 23 (56.10%) 18 (43.80%) 
History of baby WT 4 kg or more 4 (9.76%) 73 (90.24%) 
History of babies with CMF 1 (2.44%) 40 (97.56%) 
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results and normal OGTT (N = 41) 
 
Risk factors Mothers with 
GDM 
Mothers with positive 
LDG results and 
normal  OGTT 
Total 
Cases with no risk factors 4 (20.0%) 5 (23.8%) 9 (22.0%) 
Cases with risk factors 16 (80.0% ) 16 (76.2%) 32 (78.0%) 
Total 20 (6.7%) 21 (100%) 41 (100%) 
 




Table 8: Distribution of cases of GDM according to the numbers of risk factors compared to 
those with positive LDG results and normal OGTT (N = 41) 
 
No. of risk factors GDM Normal Total 
No risk factors 4 (20.0%)  5 (23.8%) 9 (22.0%) 
Cases with one risk factor 10 (50.0%) 9 (42.9%) 19 (46.3%) 
Cases with two risk factors 4 (20.0%) 7 (33.3%) 11 (26.8%) 
Cases with three risk factors 1 (5.0% ) 0 (0.0%) 1 (2.4%) 
Cases with four risk factors 1 (5.0%) 0 (0.0%) 1 (2.4%) 
Total 20.0 (100%) 21 (100%) 41 (100%) 
 




A total of 300 women were screened antenatally for gestational diabetes mellitus in order to detect 
the risk factor for developing gestational diabetes among Saudi women.  
The hospital protocol adopted a random blood sugar 11.1 mmol/L is diagnostic for diabetes 
mellitus even in pregnant women. Screening in the first visit using 50 oral glucose should be done 
for all pregnant women with random blood glucose more than 8 mmol/L. 
All mothers who had positive LDG results (13) were subjected to oral glucose tolerance test (OGTT) 
by using 100 gm oral glucose. 15 mothers (36.6%) had two or more abnormal results which were 
diagnostic for GDM, 5 mothers 12.2% had only one abnormal result suggestive of intolerance oral 





Gezira Journal Of Health Sciences 2016 vol.12(1) 
Gezira Journal Of Health Sciences 2016 vol.12(1) 
tolerance test and their final diagnosis was abnormal LDG results and normal OGTT. Patients with 
single abnormal value IOGTT results behaved like cases of GDM and were significantly different 
from mothers with normal OGTT (14). There was no difference in the early insulin secretion 
(insulinogenic index), total insulin secretion (mean insulin level) and fasting insulin concentrations 
(haemostasis models) during oral glucose tolerance test between those with IOGTT and those with 
GDM (15). Mothers with IOGTT were regarded as pathogenic finding and the patients were treated 
similarly to the patients with gestational diabetes mellitus (15). 
The body mass index is a strong predictive means for positive LDG results. More patients with 
GDM could be diagnosed if OGTT was repeated to those with positive LDG results up to 36 
weeks. Our results are similar to other studies in which obesity influences LDG results (1). Increase 
in body mass index is associated with increased incidence of GDM (37, 38) even in low risk 
population (2). 
Mothers with positive LDG results "78% (32/41)" had risk factors, so risk factors are predictive 
for abnormal LDG results. Risk factors were studied in all screened mothers with abnormal LDG 
results. The main risk factor among the screened mothers with positive LDG results is positive 
family history of diabetes mellitus as it was present in the history of 56.1% (23/41) followed by 
history of baby weighing 4 kg or more 9.76% (4/41). History of intrauterine fatal death was present 
in 7.32% (3/41). Past history of GDM and history of babies with congenital abnormalities were 
equally distributed as each of them presented by 2.44% (1/41). The of this study results are similar 
to other studies in Kuwait as they found the main risk factor was family history of diabetes mellitus, 
but they had more patients with past history of GDM (11). Also similar to other studies in Saudi 
Arabia (9), Mexico (18) and China (16). 
Risk factors were found in 80% (16/20) mothers with GDM compared to 76.2% (16/21) mothers 
with positive LDG results and normal OGTT. There is no statistical difference between them P 
value = 0.9340. Risk factors are predictive for GDM, so 23.8% (9/41) mothers with positive LDG 
results and 20% (4/20) mothers with GDM would have been missed if screening for GDM was 
done only for mothers with risk factors. This result is less than that found by other researchers (6) 
as they found that 50% of mothers with GDM had no risk factors and their recommendation was 
screening for all pregnant women based on that study. In screening pregnant women with no risk 
factors in Singapore 35.6% had positive screening higher than our results and 22.2% of them had 
GDM. The overall incidence of GDM is 8.3 % (1) they recommended universal screening. A study 
in Australian pregnant women with low risk factors reported the incidence of GDM was 8.7 less 
than our results (2) and they recommended universal screening for GDM. Good maternal and 
perinatal outcome cannot be achieved without early detection and treatment of mothers with GDM. 
One third of pregnant women with GDM have been overlooked (19) if screening for GDM was 
done only for mothers with risk factors. Universal screening for GDM increases the sensitivity test 
for screening (6) and it improves pregnancy outcome compared to selective screening (19). Universal 
screening for GDM is recommended.  
When studying the number of risk factors.  50% of diabetic mothers (10/20) had one risk factor 
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mothers with normal OGTT 33.3% (7/21) and all mothers with more than 2 risk factors were all 
diabetic. There is no statistical difference P value = 0.5647. So more diabetic mothers expected to 
be diagnosed among mothers with normal OGTT if OGTT is repeated after a month time and up 
to 36 weeks gestation (20, 21, 22).  
Risk factors were more among mothers with positive LDG results and normal OGTT "76.1% 
(16/21)" compared to mothers with negative LDG results "42.5% (110/259)". The difference is 
statistically highly significant P value = 0.0058. As 23.8% (5/21) mothers with positive LDG 
results and normal OGTT had no risk factors, they would have been missed if screening was done 
only for mothers with risk factors. Diabetic mothers from low risk group or those with no risk 
factors run the same complications as high risk group and the prevalence of GDM is still high so 
screening test for all pregnant women is the solution (1,2,19). 
Risk factors for GDM were compared between the screened and the non-screened mothers and 
were found to be similar in history of babies 4 kg or more P value =  1.000, history of intrauterine 
fetal death P value = 0.153 and the number of mothers with past history of GDM P value 0.560. 
They are different in history of babies with congenital malformations which was more among the 
screened mothers 3.3% (10/300) compared to 1.0% (3/300) of the non-screened mothers P value 
= 0.050. The two studied groups were also different in the number of mothers with family history 
of diabetes mellitus with higher percentage among the screened mothers 43.7% (131/300) 
compared to 20.0% (60/300) of the non-screened mothers. The difference is statistically highly 
significant P value = 0.00. Screening help identification of mothers at risk to develop GDM (6).  
On studying the distribution of the risk factors in the whole area of the study it was found that the 
main risk factor was family history of diabetes mellitus which was found in 31.8% (191/600) 
mothers followed by history of big baby (4 kg or more) and past history of intrauterine fetal death 
which were found in 6.7% (40/600) and 4.2% (25/600) respectively. Past history of GDM "2.0% 
(12/600)" and history of babies with congenital malformations "2.2% (13/600)" were equally 
distributed in the mothers. 
We recommend screening for GDM in high risk women but even women with low risk and no risk 
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